Dr. Francis J. Sun Joins Faculty
Please join us in welcoming Francis J. Sun, DVM, DACLAM, MBA, to the Department of Pathology as an Assistant Professor.
Huang lab discovers novel metabolic pathway critical for prostate cancer, introducing a new way to control tumor growth
Prostate cancer cells rely on an amino acid called glutamine to fuel their rapid growth and invasive behavior, as reported by Dr.
Early Prostate Cancers Can Harbor Aggressive Tumor Cells
Pathology Chair Jiaoti Huang, M.D., Ph.D., is senior author of a groundbreaking study that identifies a molecular signal that can be developed into a test to identify patients in need prostate cancer treatment early in their diagnosis.
Dr. Mikhail "Misha" Nikiforov Joins Faculty
We are pleased to welcome Mikhail (Misha) Nikiforov, Ph.D., to Duke. Nikiforov is coming to us from the Wake Forest School of Medicine and Wake Forest Comprehensive Cancer Center, where he was Professor of Cancer Biology and co-Leader of the Cancer Genetics and Metabolism Program.
Huang lab receives new NIH grant
Dr. Jiaoti Huang will receive a new National Institutes of Health (NIH) RO1 grant titled “Glutaminase I Isoforms as Personalized Biomarkers of Prostate Cancer”, starting January 1, 2022. The grant will support Huang lab’s long-term research goal of discovering novel biomarkers for the optimal diagnosis and treatment of patients with prostate cancer.
Dr. Ashley Rose Scholl Wins Pathologist-in-Training Travel Award
Ashley Rose Scholl, M.D., MSc, PGY-1, was selected to attend USCAP’s 2022 Annual Meeting with a Pathologist-in-Training Travel Award, for her project with Dr. Rami Al-Rohil, an Assistant Professor of Pathology at Duke: MALDI Imaging Mass Spectrometry Differentiates Basal Cell Carcinoma from Trichoblastoma and Trichoepithelioma.
Dr. Qianben Wang Receives Mike Slive Foundation Award
The Mike Slive Foundation has awarded a grant to Qianben Wang, PhD, to develop a CRISPR/Cas13d-based therapeutic nanoparticle targeting the FOXA2 transcription factor to inhibit neuroendocrine prostate cancer metastasis.
Novel Scoring System Improves Targeted Intervention
Laura Barisoni, MD, a Duke Pathology Professor, is the leading pathologist for the Nephrotic Syndrome study Network (NEPTUNE) and principal investigator of a study sponsored by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). It aims to study and reframe the classification of proteinuric diseases like Focal Segmental Glomerulosclerosis (FSGS) and Minimal Change Disease (MCD).
Deeper Understanding Means Better Medicine
Dr. Andrea Deyrup has been giving Grand Rounds presentations across the country with her colleague, Dr. Joseph Graves, Jr. an evolutionary biology professor from North Carolina Agricultural and Technical State University.
Jiung “Peter” Nam, an Undergraduate in the Macias Lab Presents at the Duke Cancer Institute Scientific Retreat
Jiung “Peter” Nam, a third year undergraduate student in the Macias Lab, was selected to present his abstract at the 8th Annual Duke Cancer Institute (DCI) Scientific Retreat December 3rd.